Everything below concerns mass spectrometry. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-19. Numbers and descriptions here follow the published literature rather than marketing material.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from a fragment of human growth hormone |
| Sequence basis | hGH residues 176-191 | Commonly described as a 16-amino-acid fragment |
| Appearance | White to off-white powder | Typical for lyophilized research peptides |
| Solubility | Soluble in water or aqueous buffer | Exact solubility depends on pH and purity |
| Common synonyms | AOD9604; hGH 176-191 | Spelling and punctuation vary across sources |
==== Silver ==== A tarnished-silver or aluminium paint-like feces color characteristically results when biliary obstruction of any type (white stool) combines with gastrointestinal bleeding from any source (black stool). It can also suggest a carcinoma of the ampulla of Vater, which will result in gastrointestinal bleeding and biliary obstruction, resulting in silver stool.
American Association for the Advancement of Science American Chemical Society American Society for Biochemistry and Molecular Biology Endocrine Society National Academy of Sciences Sigma XI Swiss Chemical Society Hofmann was recognized with the following awards:
== Biography == Jerome Gross was born in New York City on February 25, 1917. In 1939, he graduated from the Massachusetts Institute of Technology. While his scientific interests included astronomy and biology, he chose a career in medicine. He subsequently attended the New York University College of Medicine. After a year as an intern at Long Island College Hospital, he served two years in the Army Medical Corps. Gross believed that clues to diseases such as rheumatic fever would be found in the molecular structure and biology of connective tissue. He returned to M.I.T. to join the laboratory of Francis O. Schmitt as a Research Associate, where he began research on structural macromolecules utilizing chemical and electron microscopical methods. Despite many important observations on hyaluronic acid and elastin, he chose to focus on collagen. He was attracted to Harvard Medical School and the Massachusetts General Hospital by Walter Bauer, who thought that many of the secrets of rheumatoid arthritis and rheumatic fever could be uncovered by similar methods. Gross's pioneering findings that collagen molecules could be extracted from tissues using solutions of neutral salt or dilute acid and reconstituted into various structures opened up the field of collagen research. Gross then began to study collagen structure in animal models of human wound healing. In the late 1950s, he became interested in lathyrism and, with Charles Levene, made the critical observations that lathyrism resulted from abnormal aggregation and defective cross-linking of collagen molecules.
== Work history == While researching at Case Western Reserve, Tippett moonlighted as an emergency room physician and instructor in Emergency and Outpatient Medicine. He spent much of his early clinical career (1989–1995) in Emergency Medicine in Ohio and California. He received his board certification in Internal Medicine in 1987. Between 1993 and 2000, he served on the board of the Computer Ethics Institute. He served as executive director of The Pacific Foundation for Science and Medicine from 1988 to 1992, an intersection of his clinical career with an emerging focus on technology, particularly cybersecurity, and the use and access protocols of the Internet. It was in his role as president and chairman of Certus International, a publisher and developer of PC anti-virus and security software, that Tippett applied his research insights as a biochemist to the concept of computer "viruses" to develop the anti-virus software, "Vaccine," which was later purchased by Symantec in 1992. His CEO role with Cybertrust led to a merger of Cybertrust by Verizon, and Tippett's role in the Verizon healthcare and security innovations divisions. Tippett served as chairman of the Alliance for Internet Security in 2000. He represented Verizon on the board of directors of The Open Identity Exchange (OIX) and the Information Card Foundation.
For example, the Archbishop of Reggio Calabria, Carmelo Pujia, an interventionist on the eve of World War, had a prayer composed praising the glory of the homeland and the Italian flag. Under the Fascist regime, concentration camps were built in Calabria and used to imprison foreigners whose presence was considered undesirable, such as Chinese immigrants and foreign (though not Italian) Jews together with members of the Romani minority, whose nomadic lifestyle was viewed as anti-social. The camps operated from 1938 to 1943. They were harsh, butt not death camps, (the majority of those imprisoned survived).
Sources: en.wikipedia.org
(2026) study the composition of the Quaternary small mammal assemblage from the Araras Ravine at the Lajedo de Soledade site (Rio Grande do Norte, Brazil), providing evidence of similarities with extant faunas from open environments in the Caatinga and Cerrado. A study on the late Pleistocene/early Holocene fauna from the Pikimachay Cave (Peru) is published by Yataco et al. (2026), who interpret the studied site as likely to be a giant ground sloth burrow that was also used by carnivores and/or humans. Hullot et al. (2026) propose a standardized methodological framework for the study of enamel histology in fossil taxa, and apply it to the study of enamel histology and growth of molars of toxodont notoungulates Pleurostylodon modicus, Eurygenium pacegnum, Adinotherium ovinum and Nesodon imbricatus. Von Koenigswald (2026) reviews the morphological diversity of incisors and canines in extant and fossil mammals. Wilson et al. (2026) compare the wear of bilophodont teeth in xenungulates, pyrotheres, fossil and modern tapirs and in extant marsupials, and interpret their findings as suggestive of browsing feeding behaviors of xenungulates and fossil tapirs, as well as of variable diets of different members of Pyrotheria. Evidence of preservation of amino acids in tooth enamel of fossil proboscideans, equids and rhinocerotids dating back as far as 48 million years is presented by Gatti et al. (2026). Herrando-Pérez et al.
== Herbalism == A. mongholicus is used in traditional Chinese medicine (TCM). A. mongholicus is a component in Lectranal, a food supplement used in treatment of seasonal allergic rhinitis, though there is limited evidence of its effectiveness.
=== Microscopy and imaging === An infrared microscope allows samples to be observed and spectra measured from regions as small as 5 microns across. Images can be generated by combining a microscope with linear or 2-D array detectors. The spatial resolution can approach 5 microns with tens of thousands of pixels. The images contain a spectrum for each pixel and can be viewed as maps showing the intensity at any wavelength or combination of wavelengths. This allows the distribution of different chemical species within the sample to be seen. This technique has been applied in various biological applications including the analysis of tissue sections as an alternative to conventional histopathology, examining the homogeneity of pharmaceutical tablets, and for differentiating morphologically-similar pollen grains.
Plutonium-238, curium-244, strontium-90, and most recently americium-241 are the most often cited candidate isotopes, but 43 more isotopes out of approximately 1,300 were considered at the beginning in the 1950s. The table below does not necessarily give power densities for the pure material but for a chemically inert form. For actinides this is of little concern as their oxides are usually inert enough (and can be transformed into ceramics further increasing their stability), but for alkali metals and alkaline earth metals like caesium or strontium respectively, relatively complex (and heavy) chemical compounds have to be used. For example, strontium is commonly used as strontium titanate in RTGs, which increases molar mass by about a factor of 2. Furthermore, depending on the source, isotopic purity may not be obtainable. Plutonium extracted from spent nuclear fuel has a low share of Pu-238, so plutonium-238 for use in RTGs is usually purpose-made by neutron irradiation of neptunium-237, further raising costs. Caesium in fission products is almost equal parts Cs-135 and Cs-137, plus significant amounts of stable Cs-133 and, in "young" spent fuel, short lived Cs-134. If isotope separation, a costly and time-consuming process, is to be avoided, this has to be factored in, too. While historically RTGs have been rather small, there is in theory nothing preventing RTGs from reaching into the megawattthermal range of power.
== History == This method was developed by Solomon Berson and Rosalyn Sussman Yalow at the Veterans Administration Hospital in the Bronx, New York. This revolutionary development earned Dr. Yalow the Nobel Prize for Medicine in 1977, the second woman ever to win it. In her acceptance speech, Dr. Yalow said, "The world cannot afford the loss of the talents of half its people if we are to solve the many problems which beset us." Yalow shared the Nobel Prize with Roger Guillemin, and Andrew Schally who earned the prize based on their research into "the peptide hormone production of the brain".
Sources: en.wikipedia.org
If a lich's corporeal body is destroyed, the portion of its soul that remained in the body does not pass on to the afterlife; rather, it persists in a non-corporeal form capable of being reconstituted or resurrected. However, if all of a lich's soul-artifacts are destroyed, its only remaining anchor to the material world becomes its corporeal body—meaning that its destruction would result in permanent death.
Iron-pyrite FeS2 represents the prototype compound of the crystallographic pyrite structure. The structure is cubic and was among the first crystal structures solved by X-ray diffraction. It belongs to the crystallographic space group Pa3 and is denoted by the Strukturbericht notation C2. Under thermodynamic standard conditions the lattice constant
== Clinical relevance == Interference with aminoacylation may be useful as an approach to treating some diseases: cancerous cells may be relatively vulnerable to disturbed aminoacylation compared to healthy cells. The protein synthesis associated with cancer and viral biology is often very dependent on specific tRNA molecules. For instance, for liver cancer charging tRNA-Lys-CUU with lysine sustains liver cancer cell growth and metastasis, whereas healthy cells have a much lower dependence on this tRNA to support cellular physiology. Similarly, hepatitis E virus requires a tRNA landscape that substantially differs from that associated with uninfected cells. Hence, inhibition of aminoacylation of specific tRNA species is considered a promising novel avenue for the rational treatment of a plethora of diseases.
== Pharmacology == The drug potentiates the tropomyosin receptor kinases TrkA, TrkB, and TrkC with EC50Tooltip half-maximal effective concentration values of 382 nM, 295 nM, and ~330 nM, respectively. As a positive allosteric modulator of TrkA and TrkB, ACD856 potentiates the effects of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). In addition to the tropomyosin receptor kinases, ACD856 is also a similarly potent positive allosteric modulator of certain other receptor tyrosine kinases, including the insulin-like growth factor 1 receptor (IGF1R) and the fibroblast growth factor receptor 1 (FGFR1). However, its efficacies at the IGF1R and FGFR1 were much lower than at the TrkA, TrkB, and TrkC. In animals, ACD856 has been found to reverse scopolamine- and dizocilpine (MK-801)-induced memory impairment, to improve age-related memory deficits, and to have sustained antidepressant-like activity. It has also been reported to possess neuroprotective properties. In humans, the drug has been shown to cross the blood–brain barrier and to induce dose-dependent changes in electroencephalogram parameters. No significant tolerability or safety concerns have been identified in preclinical research or phase 1 clinical trials. The drug's clinical pharmacokinetics have been characterized and its elimination half-life is approximately 19 hours.
Mathias Uhlén (born May 1954) is a Swedish scientist and Professor of Microbiology at Royal Institute of Technology (KTH), Stockholm. After a post-doc period at the EMBL in Heidelberg, Germany, he became professor in microbiology at KTH in 1988. His research is focused on protein science, antibody engineering and precision medicine and range from basic research in human and microbial biology to more applied research, including clinical applications. He is member of several academies and societies, including Royal Swedish Academy of Science (KVA), National Academy of Engineering (NAE) and the Swedish Academy of Engineering Science (IVA). Dr Uhlen was the Founding Director of the national infrastructure Science for Life Laboratory (SciLifeLab) from 2010 to 2015.
Sources: en.wikipedia.org
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.
It is commonly described as a 16-amino-acid peptide based on residues 176-191 of human growth hormone. Some sources vary in notation, so checking the stated sequence is useful.
It is not typically described as a standalone natural hormone. The sequence is derived from the C-terminal region of human growth hormone, but the synthetic peptide is a laboratory-made construct.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.